International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8330536
Original Article
A Comparative Study of Patellar Resurfacing Versus It's Retention in Total Knee Arthroplasty
 ,
Published
Aug. 31, 2023
Abstract

Background: Total knee arthroplasty is one of the most successful operations in modern orthopedics with less than 5% complications. Unfortunately, half of them are patella complications which naturally make patellar resurfacing a topic of debate since the advent of this surgery. In this randomized prospective left right study, we try to evaluate the best means of overcoming this problem.

 

Materials and Methods: 60 knees were operated which were in a period of 3 years and followed up for a mean of 21 months. Randomisation was achieved by resurfacing all right knees while retaining all left knees. We had equal number of left and right knees and the results were evaluated with the help of Knee Society score, Patellar score, anterior knee pain and complication rate.

 

Results: The incidence of anterior pain in knees without patellar resurfacing (24%) was significantly higher than that in knees with patellar resurfacing (12%). This pain was not related to pre op pain and was not related to age, sex, obesity, or grade of chondromalacia of the patella. There were no patella-femoral complications in the resurfaced groups as such.

 

Conclusion: If equal time and importance is given to the third component of the total knee arthroplasty it helps in preventing the so often encountered patella-femoral complications. This leads to over all better functional results especially lesser incidence of post op anterior knee pain. More importantly selective knee resurfacing is no better as other indicators of resurfacing were proved to be not of much use in this study.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
2865 Views
433 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved